Cargando…

Tirofiban: A Rare Cause of Thrombocytopenia in a Patient Undergoing Percutaneous Coronary Intervention

Patients admitted to the hospital can develop thrombocytopenia due to multifactorial causes. It can be pseudo-thrombocytopenia or true thrombocytopenia. Among patients admitted for chest pain, coronary angiography (CAG) is a common diagnostic test to evaluate patients for coronary artery disease (CA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gulati, Amit, Tiwari, Aparna, Shetty, Vijay, Nwosu, Ifeanyi, Khurana, Sakshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544618/ https://www.ncbi.nlm.nih.gov/pubmed/34722029 http://dx.doi.org/10.7759/cureus.18217

Ejemplares similares

Hyphema: A Rare Complication of Periprocedural Antiplatelets and Anticoagulants Following Percutaneous Coronary Intervention
por: Gulati, Amit, et al.
Publicado: (2021)

Right Coronary Artery Pseudoaneurysm With Hemopericardium: A Rare Complication of Percutaneous Coronary Intervention
por: Byrnes, Sean, et al.
Publicado: (2020)

Severe thrombocytopenia induced by tirofiban after percutaneous coronary intervention: a case report
por: Wang, Ze-Mu, et al.
Publicado: (2023)

Tirofiban-induced thrombocytopenia
por: Wang, Jun, et al.
Publicado: (2023)

Recognizing Kounis Syndrome: A Report of Type 2 Kounis Syndrome and a Brief Review of Management
por: Clemen, Britney, et al.
Publicado: (2021)

Tirofiban Induced Thrombocytopenia: A Rare but Severe Adverse Effect
por: Rawala, Muhammad Shabbir, et al.
Publicado: (2020)

Prolonged Use of Tirofiban Infusion Without Percutaneous Coronary Intervention To Achieve Optimal Results in a COVID-19 Positive Patient With Inferior ST Segment Elevated Myocardial Infarction (STEMI) Secondary to Thromboembolism: A Case Report
por: Khan, Zahid, et al.
Publicado: (2022)

A Simple Clinical Pre-procedure Risk Model for Predicting Thrombocytopenia Associated With Periprocedural Use of Tirofiban in Patients Undergoing Percutaneous Coronary Intervention
por: Yi, Yi-Hu, et al.
Publicado: (2018)

Outcomes and Predictors of Mortality in Hospitalized Frail Patients Undergoing Percutaneous Coronary Intervention
por: Desai, Rupak, et al.
Publicado: (2019)

Severe thrombocytopenia following tirofiban infusion
por: Panduranga, Prashanth, et al.
Publicado: (2011)

COVID-19 mRNA Vaccine-Associated Myocarditis
por: Kyaw, Htin, et al.
Publicado: (2022)

Paradoxical Thromboembolic Ischemic Stroke Following Tissue Plasminogen Activator Instillation for Clogged Central Venous Dialysis Catheter
por: Nwosu, Ifeanyi, et al.
Publicado: (2021)

Management of Stent Thrombosis Post-Percutaneous Coronary Intervention and Associated Rare Complications
por: Fadah, Kahtan, et al.
Publicado: (2021)

The Role of Cardiac Imaging in the Evaluation of Cardiac Involvement in Systemic Diseases
por: Kumar, Kelash, et al.
Publicado: (2021)

Tirofiban-Induced Thrombocytopenia Occurring with Crohn's Disease
por: Ibrahim, Toni, et al.
Publicado: (2016)

Premedication to reduce anxiety in patients undergoing coronary angiography and percutaneous coronary intervention
por: Vlastra, Wieneke, et al.
Publicado: (2018)

A Young Heart With Coronary Dissection
por: Kumar, Kelash, et al.
Publicado: (2022)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Nitrates as a Marker of Multiple Co-morbidities and Increased Mortality in Patients Undergoing Percutaneous Coronary Intervention (PCI)
por: Yager, Neil, et al.
Publicado: (2022)

A Cardiologists’ Survey on the Use of Anticoagulants and Antiplatelets in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Those Undergoing Percutaneous Coronary Intervention in India
por: Kulkarni, Namrata, et al.
Publicado: (2023)

Local fluid dynamics in patients with bifurcated coronary lesions undergoing percutaneous coronary interventions
por: Genuardi, Lorenzo, et al.
Publicado: (2021)

Study of Association Between Different Coronary Artery Disease Presentations and Its Effect on Short-Term Mortality, Readmission, and Cost in Patients Undergoing Percutaneous Coronary Interventions
por: Ahmad, Mansoor, et al.
Publicado: (2021)

A Case Report of Native Coronary Artery Thrombosis With Heparin-Induced Thrombocytopenia
por: Hein, Aung, et al.
Publicado: (2023)

Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
por: Habibi, Zarina, et al.
Publicado: (2023)

Prevalence & Factors Associated With Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention at a Tertiary Healthcare Facility in Tanzania
por: Hooda, Faisal, et al.
Publicado: (2023)

Predictors of periprocedural complications in patients undergoing percutaneous coronary interventions within coronary artery bypass grafts
por: Januszek, Rafał A., et al.
Publicado: (2020)

Assessment of the Efficacy and Safety of Early Intracoronary Nicorandil Administration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Gupta, Himanshu, et al.
Publicado: (2022)

Diurnal Variation in Outcomes of Percutaneous Coronary Intervention
por: Malik, Jahanzeb, et al.
Publicado: (2020)

Contrast-induced Nephropathy Following Percutaneous Coronary Intervention at a Tertiary Cardiac Center in Nepal
por: Mandal, Amrendra, et al.
Publicado: (2018)

Incidence of Cardiac Arrhythmias in Acute Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention and Associated Outcomes During the First 24 Hours
por: Shah, Jehangir A, et al.
Publicado: (2021)

Hospitalization Rates, Prevalence of Cardiovascular Manifestations and Outcomes Associated With Amyloidosis in the United States
por: Oladiran, Oreoluwa D, et al.
Publicado: (2021)

A Case Of Awake Percutaneous Extracorporeal Membrane Oxygenation For High-risk Percutaneous Coronary Intervention
por: Liu, Shuangbo, et al.
Publicado: (2017)

Inadvertent Septal Ablation During Percutaneous Coronary Intervention
por: Gao, Feng, et al.
Publicado: (2021)

Coeliac Disease: A Rare Cause of Myocardial Infarction With Non-Obstructive Coronary Arteries
por: Leghlimi, Hasnaa, et al.
Publicado: (2023)

Case report: reuse of tirofiban leads to very severe thrombocytopenia
por: Li, Yuqing, et al.
Publicado: (2023)

Giant Coronary Aneurysm Causing Ostial Occlusion of Coronary Artery by Mass Effect: A Case Report
por: Fanai, Vanlalmalsawmdawngliana, et al.
Publicado: (2021)

Intracoronary administration of tirofiban during percutaneous coronary intervention facilitates patients with acute coronary syndrome
por: Jia, Helei, et al.
Publicado: (2017)

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
por: Krishnamurthy, Arvindra, et al.
Publicado: (2019)

A Single Transradial Guiding Catheter in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Door-to-Balloon Optimized Strategy
por: Cervantes-Nieto, Jorge Antonio, et al.
Publicado: (2023)

Current Practice of Percutaneous Coronary Intervention in Patients With Coagulation Disorders
por: El Khoury, Michel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6gebljpujtq1e61t37lqbquh7d